Bloodwork question about melanotan II. Baseline, a year in, and the numbers moved in a direction I did not expect.

I would rather have a narrow conclusion and be right than a broad one and be interesting.

Vivid dreams and mild headache for the first 3 days, then nothing. Textbook for this class, apparently.

Forum consensus and published consensus diverged here about five years ago and never reconverged.

What the peptide class does pharmacologically does not require the subjective effect to be large to be real.

Animal data is much of what exists here and the human stuff is thin and small.

The interesting question is not whether it works but for whom and at what cost.